Degner NR, et al. - An evaluation is performed of potential confounding variables in addressing the impact of diabetes mellitus (DM) on tuberculosis (TB) treatment outcomes. This study suggests that despite multiple potential confounding variables, DM poses an increased risk of adverse TB treatment outcomes. Findings reveal a marked association between metformin use and decreased mortality during TB treatment, suggesting a potential role for this agent as adjunctive, host-directed therapy.